Active specific immunotherapy, using vaccines with autologous tumour cells and BCG, significantly reduces the rate of tumour recurrence in stage II colon cancer ...

Colon cancer remains a major threat to human life. In 2012, 103 170 new cases of colon cancer were diagnosed and 51 690 deaths occurred from colorectal cancer in the United States. 1 Although the rate ...

In the adjuvant setting, 5-FU provided overall survival — about 23 months — similar to that of gemcitabine (Gemzar), according to the results of a new randomized trial presented here at the American ...

Next Generation Capecitabine (NGC-Cap) provides patients with 2-10 times greater exposure to its 5-FU cancer treatment metabolite than capecitabine administration NGC-Cap was better tolerated with ...

Radioembolization of unresectable primary and secondary hepatic malignancies using yttrium-90: The University of Texas at Houston experience. Background: Gemcitabine and 5-fluorouracil (5-FU) ...